- During the COVID-19 era, both cancer diagnosis and treatment must undergo a large shift as a large part of the cancer process revolves around patient interaction directly with a physician
- Due to this, there has now been an uptick in radiology usage to treat more invasive cancers that would have before required intimate surgeries
- The more widespread adoption and use of Hypofractionation, the use of more potent treatments over a shorter period of time, must also me adopted as it will allow for shorter recovery time and lower the high-risk window which most cancer patients have
- The paper addresses the shortcomings of telehealth in the cancer treatment journey as prior to COVID-19 many telehealth consultations were only really used for a second opinion with a physician that may be further away, this primary usage has not entirely changed as it is impossible to perform tasks like radiological imaging through a telehealth visit and patients must physically go to a hospital to receive some forms of treatment


The Specific Effects on Cancer Care During COVID-19 from a Radiological Perspective

- This paper briefly mentions how some radiological techniques could be utilized to treat symptoms of COVID-19
- The paper describes how some early 20th century literature describes the use of radiology to treat pneumonia and how a similar style of treatment is currently being used by James Cancer Center at The Ohio State University


The Crossover of the Field of Radiology into COVID-19 Treatment

- This paper provides a rough outline into how the area of radiation oncology and how that field has changed as COVID-19 has surged
- It provides a brief look at how cancer management as a whole has shift during the pandemic as well as how the field of radiation oncology could be utilized for COVID-19 treatment


Ohio State University, Columbus

- The implications of COVID-19 in radiation oncology in the United States

General Cancer and Radiological Treatment

Odei, B., & Quick, A. (2020). The implications of COVID-19 in radiation oncology in the United States. Current oncology (Toronto, Ont.), 27(5), 279–280. https://doi.org/10.3747/co.27.7095

URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7606045/


The implications of COVID-19 in radiation oncology in the United States

- Since cancer patients are at such a high risk for COVID-19, it is very important that physicians keep their treatment regimens for all medications under extreme control and very monitored
- It was identified that patients with hematologic cancers tend to have poorer outcomes than those with solid tumors and therefore they must be kept under constant surveillance for COVID-19 infection
- The purpose of this paper is to give a 1-year recap on cancer management techniques instituted during the COVID-19 pandemic


Learn Before

Related

Learn After